Opin vísindi

Fletta eftir höfundi "Lehtimäki, Lauri"

Fletta eftir höfundi "Lehtimäki, Lauri"

Röðun: Raða: Niðurstöður:

  • Pfeffer, Paul E; Ali, Nasloon; Murray, Ruth; Ulrik, Charlotte; Tran, Trung N; Maspero, Jorge; Peters, Matthew; Christoff, George C; Sadatsafavi, Mohsen; Torres-Duque, Carlos A; Altraja, Alan; Lehtimäki, Lauri; Papadopoulos, Nikolaos G; Salvi, Sundeep; Costello, Richard W; Cushen, Breda; Heffler, Enrico; Iwanaga, Takashi; Al-Ahmad, Mona; Larenas-Linnemann, Désirée; Kuna, Piotr; Fonseca, João A; Al-Lehebi, Riyad; Rhee, Chin Kook; Perez-de-Llano, Luis; Perng Steve, Diahn-Warng; Mahboub, Bassam; Wang, Eileen; Goh, Celine; Lyu, Juntao; Newell, Anthony; Alacqua, Marianna; Belevskiy, Andrey S; Bhutani, Mohit; Bjermer, Leif; Björnsdóttir, Unnur Steina; Bourdin, Arnaud; Bulow, Anna von; Busby, John; Canonica, Giorgio Walter; Cosio, Borja G; Dorscheid, Delbert R; Muñoz-Esquerre, Mariana; FitzGerald, J Mark; Gil, Esther Garcia; Gibson, Peter G; Heaney, Liam G; Hew, Mark; Hilberg, Ole; Hoyte, Flavia; Jackson, David J; Koh, Mariko Siyue; Ko, Hsin-Kuo Bruce; Lee, Jae Ha; Lehmann, Sverre; Chaves Loureiro, Cláudia; Lúðvíksdóttir, Dóra; Menzies-Gow, Andrew N; Mitchell, Patrick; Papaioannou, Andriana I; Popov, Todor A; Porsbjerg, Celeste M; Salameh, Laila; Sirena, Concetta; Taillé, Camille; Taube, Christian; Tohda, Yuji; Wechsler, Michael E; Price, David B (2023-07)
    BACKGROUND: Patients with severe asthma may present with characteristics representing overlapping phenotypes, making them eligible for more than one class of biologic. Our aim was to describe the profile of adult patients with severe asthma eligible ...
  • Frix, Anne Noelle; Heaney, Liam G.; Dahlén, Barbro; Mihaltan, Florin; Sergejeva, Svetlana; Popović-Grle, Sanja; Sedlak, Vratislav; Lehtimäki, Lauri; Bourdin, Arnaud; Korn, Stephanie; Zervas, Eleftherios; Csoma, Zsuzsanna; Lúðvíksdóttir, Dóra; Butler, Marcus; Canonica, Giorgio Walter; Grisle, Ineta; Bieksiene, Kristina; Ten Brinke, Anneke; Kuna, Piotr; Loureiro, Claudia Chaves; Nenasheva, Natalia M.; Lazic, Zorica; Škrgat, Sabina; Ramos-Barbon, David; Leuppi, Joerg; Gemicioglu, Bilun; Bossios, Apostolos; Porsbjerg, Celeste M.; Bel, Elisabeth H.; Djukanovic, Ratko; Louis, Renaud (2022-10-01)
    Introduction Treatment with biologics for severe asthma is informed by international and national guidelines and defined by national regulating bodies, but how these drugs are used in real-life is unknown. Materials and methods The European Respiratory ...
  • FitzGerald, J. Mark; Tran, Trung N.; Alacqua, Marianna; Altraja, Alan; Backer, Vibeke; Bjermer, Leif; Björnsdóttir, Unnur; Bourdin, Arnaud; Brusselle, Guy; Bulathsinhala, Lakmini; Busby, John; Canonica, Giorgio W.; Carter, Victoria; Chaudhry, Isha; Cho, You Sook; Christoff, George; Cosio, Borja G.; Costello, Richard W.; Eleangovan, Neva; Gibson, Peter G.; Heaney, Liam G.; Heffler, Enrico; Hew, Mark; Hosseini, Naeimeh; Iwanaga, Takashi; Jackson, David J.; Jones, Rupert; Koh, Mariko S.; Le, Thao; Lehtimäki, Lauri; Lúðvíksdóttir, Dóra; Maitland-van der Zee, Anke H.; Menzies-Gow, Andrew; Murray, Ruth B.; Papadopoulos, Nikolaos G.; Perez-de-Llano, Luis; Peters, Matthew; Pfeffer, Paul E.; Popov, Todor A.; Porsbjerg, Celeste M.; Price, Chris A.; Rhee, Chin K.; Sadatsafavi, Mohsen; Tohda, Yuji; Wang, Eileen; Wechsler, Michael E.; Zangrilli, James; Price, David B. (Springer Science and Business Media LLC, 2020-08-14)
    Background: Severe asthma exerts a disproportionately heavy burden on patients and health care. Due to the heterogeneity of the severe asthma population, many patients need to be evaluated to understand the clinical features and outcomes of severe ...
  • Porsbjerg, Celeste; Ulrik, Charlotte; Skjold, Tina; Backer, Vibeke; Laerum, Birger; Lehman, Sverre; Janson, Crister; Sandstrøm, Thomas; Bjermer, Leif; Dahlen, Barbro; Lundbäck, Bo; Ludviksdottir, Dora; Björnsdóttir, Unnur; Altraja, Alan; Lehtimäki, Lauri; Kauppi, Paula; Karjalainen, Jussi; Kankaanranta, Hannu (Informa UK Limited, 2018-01)
    Although a minority of asthma patients suffer from severe asthma, they represent a major clinical challenge in terms of poor symptom control despite high-dose treatment, risk of exacerbations, and side effects. Novel biological treatments may benefit ...
  • Hansen, Susanne; von Bülow, Anna; Sandin, Patrik; Ernstsson, Olivia; Janson, Christer; Lehtimäki, Lauri; Kankaanranta, Hannu; Ulrik, Charlotte; Aarli, Bernt Bøgvald; Fues Wahl, Hanna; Geale, Kirk; Tang, Sheila Tuyet; Wolf, Maija; Larsen, Tom; Altraja, Alan; Backman, Helena; Kilpeläinen, Maritta; Viinanen, Arja; Lúðvíksdóttir, Dóra; Kauppi, Paula; Sverrild, Asger; Lehmann, Sverre; Backer, Vibeke; Yasinska, Valentyna; Skjold, Tina; Karjalainen, Jussi; Bossios, Apostolos; Porsbjerg, Celeste (2023-03-01)
    BACKGROUND: Real-life evidence on prevalence and management of severe asthma is limited. Nationwide population registries across the Nordic countries provide unique opportunities to describe prevalence and management patterns of severe asthma at ...